Affymax Inc (AFFY) 10-Q Quarterly Report May 2014

Document and Entity Information	3 Months Ended
Document and Entity Information	Mar. 31, 2014	Apr. 30, 2014
Entity Information [Line Items]
Entity Registrant Name	AFFYMAX INC
Entity Central Index Key	0001158223
Document Type	10-Q
Document Period End Date	Mar. 31, 2014
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Entity Current Reporting Status	Yes
Entity Filer Category	Non-accelerated Filer
Entity Common Stock, Shares Outstanding		37,490,095
Document Fiscal Year Focus	2014
Document Fiscal Period Focus	Q1

Please wait while we load the requested 10-Q report or click the link below:

https://last10k.com/sec-filings/report/1158223/000115822314000003/affy03311410q.htm

View differences made from one quarter to another to evaluate Affymax Inc's financial trajectory

Compare SEC Filings Year-over-Year (YoY) and Quarter-over-Quarter (QoQ) — *Sample 10-K Year-over-Year (YoY) Comparison*

Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were ~~removed~~ , added and changed by Affymax Inc.

Continue

Assess how Affymax Inc's management team is paid from their Annual Proxy

Affymax Inc's Definitive Proxy Statement (Form DEF 14A) filed after their 2014 10-K Annual Report includes:

Voting Procedures
Board Members
Executive Team
Salaries, Bonuses, Perks
Peers / Competitors

Continue

Financial Statements, Disclosures and Schedules

Inside this 10-Q Quarterly Report

Ticker: AFFY
CIK: 1158223
Form Type: 10-Q Quarterly Report
Accession Number: 0001158223-14-000003
Submitted to the SEC: Tue May 06 2014 4:23:03 PM EST
Accepted by the SEC: Tue May 06 2014
Period: Monday, March 31, 2014
Industry: Pharmaceutical Preparations